Regulated cell death pathways in kidney disease
Ana B. Sanz(Instituto de Salud Carlos III), Alberto Ortíz(Universidad Pontificia de Salamanca)
Cited by 337
Related Papers
The systemic nature of CKD
|Nature Reviews Nephrology|2017|438
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
|The Lancet|2014|433
Tenofovir Nephrotoxicity: 2011 Update
|AIDS Research and Treatment|2011|293
Lipid management in patients with chronic kidney disease
|Nature Reviews Nephrology|2018|275
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|225